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Abstract
The Horizon2020 LifeCycle Project is a cross-cohort collaboration which brings together data from multiple birth cohorts 
from across Europe and Australia to facilitate studies on the influence of early-life exposures on later health outcomes. A 
major product of this collaboration has been the establishment of a FAIR (findable, accessible, interoperable and reusable) 
data resource known as the EU Child Cohort Network. Here we focus on the EU Child Cohort Network’s core variables. 
These are a set of basic variables, derivable by the majority of participating cohorts and frequently used as covariates or 
exposures in lifecourse research. First, we describe the process by which the list of core variables was established. Second, 
we explain the protocol according to which these variables were harmonised in order to make them interoperable. Third, we 
describe the catalogue developed to ensure that the network’s data are findable and reusable. Finally, we describe the core 
data, including the proportion of variables harmonised by each cohort and the number of children for whom harmonised core 
data are available. EU Child Cohort Network data will be analysed using a federated analysis platform, removing the need to 
physically transfer data and thus making the data more accessible to researchers. The network will add value to participating 
cohorts by increasing statistical power and exposure heterogeneity, as well as facilitating cross-cohort comparisons, cross-
validation and replication. Our aim is to motivate other cohorts to join the network and encourage the use of the EU Child 
Cohort Network by the wider research community.
Keywords Birth cohort · Cross-cohort collaboration · Lifecourse epidemiology · Data harmonisation · FAIR (findable, 
accessible, interoperable and reusable) principles
Introduction
Non-communicable diseases (NCDs) such as cardiovascu-
lar disease, cancer, chronic respiratory disease and diabetes 
represent a major global health challenge and are the leading 
cause of death worldwide. Of the 56.9 million deaths that 
occurred in 2016, 40.5 million (71%) were from NCDs [1]; 
this number is estimated to rise to 52 million by 2030 [2]. 
To address the growing economic and health burden that 
NCDs represent, the United Nations’ Sustainable Develop-
ment Goal (SDG) target 3.4 aims to reduce premature mor-
tality due to NCDs by one third by 2030 through prevention, 
treatment and promotion of mental health and wellbeing [1].
Early-life offers an important window of opportunity for 
achieving this target. Evidence strongly suggests that envi-
ronmental conditions and exposures during intrauterine and 
early postnatal life can influence anatomical, physiological 
and biochemical processes and, in so doing, impact future 
 * Angela Pinot de Moira 
 anpi@sund.ku.dk
Extended author information available on the last page of the article
566 A. Pinot de Moira et al.
1 3
health [3]. Longitudinal pregnancy and child cohort studies 
provide a means of investigating this phenomenon, includ-
ing how early-life exposures influence health trajectories, 
and identifying potential early-life interventions to improve 
health outcomes [4]. However, such studies are expensive to 
establish and maintain, which often prohibits the large-scale 
studies required to investigate rare outcomes or exposures, or 
conduct more advanced statistical analyses to investigate, for 
example, causality or lifecourse health trajectories.
Cross-cohort collaborations offer a cost-effective 
approach to increase the statistical power of such analyses. 
They also provide other benefits such as increased exposure 
heterogeneity, facilitated cross-cohort comparisons, the abil-
ity to cross-validate, replicate and establish the generalis-
ability of findings, and the opportunity to share expertise 
and knowledge. In recent years, a number of such collabo-
rations have been successfully established, for example the 
CHICOS (www. chico sproj ect. eu), BioSHARE [5], HELIX 
[6] (www. proje cthel ix. eu), PACE [7], EGG/EAGLE [8], 
ESCAPE [9] (www. escap eproj ect. eu) and Enrieco [10] 
(www. enrie co. org) projects, which have led to the identifi-
cation of a number of associations that may have otherwise 
gone unobserved [11–28]. More recently, in 2017, building 
on expertise gained from these collaborations, the Horizon 
2020-funded LifeCycle project was established [29] (www. 
lifec ycle- proje ct. eu).
LifeCycle aims to facilitate the utilisation of data from 
mainly European, but also some non-European, cohort stud-
ies for research. It has a particular focus on preconception, 
fetal and early childhood exposures and their influence on 
cardio-metabolic, respiratory and mental health trajectories. 
To achieve its aim, LifeCycle has established the EU Child 
Cohort Network, a sustainable data resource and infrastruc-
ture which is built around making each participating cohort’s 
data findable, accessible, interoperable and reusable (FAIR) 
[30]. The network currently holds data on approximately 
250,000 children and their parents from an initial 16 Euro-
pean and one Australian cohort.
An overview of the EU Child Cohort Network, including 
the data management and governance structure on which 
the network is based, plus its primary research themes, was 
provided by Jaddoe et al. in a previous edition of this journal 
[29]. Here we provide a detailed description of the EU Child 
Cohort Network’s core variables, which are a set of basic 
variables, derivable by the majority of participating cohorts 
and required for most analyses in lifecourse research. We 
describe firstly the process by which the list of core vari-
ables was established; secondly the protocol developed to 
harmonise these core data, which defines the harmonisa-
tion process adopted generally within LifeCycle; thirdly 
the catalogue developed to ensure that all EU Child Cohort 
Network data are both findable and reusable; finally the core 
data themselves, including the variables harmonised by each 
cohort and the total number of children with harmonised 
data. Our aims are to: (1) enable an accurate assessment of 
the quality and validity of the harmonised core data through 
transparency of our methods; (2) motivate other cohorts 
to contribute to the network; (3) encourage the use of the 




An overview of the 17 cohorts that established the EU Child 
Cohort Network is provided in Table 1. Further details of 
each cohort can be found in Jaddoe et al. [29], the EU Child 
Cohort Network Variable Catalogue (http:// catal ogue. lifec 
ycle- proje ct. eu) and each cohort’s profile paper [31–49]. The 
network is open for other cohorts to join, provided they meet 
the following criteria: (1) commenced before or during preg-
nancy or in infancy; (2) plan to follow-up or already have 
followed-up the cohort throughout childhood; (3) are willing 
to harmonise data and make them available to researchers 
using the network. Cohorts can join the network by con-
tacting the coordinating centre (lifecycle@erasmusmc.nl). 
Similarly, proposals for research based on EU Child Cohort 
Network data can be put forward by both LifeCycle partners 
and external researchers by also contacting the coordinat-
ing centre (lifecycle@erasmusmc.nl). Proposals for research 
may be based on all EU Child Cohort Network cohorts or a 
subset of cohorts with available data; they may also include 
requests for further data harmonisation, which can likewise 
be restricted to a subset of cohorts with data.
Harmonisation
The EU Child Cohort Network’s core variables are a set of 
basic, predominantly “lowest common denominator” vari-
ables, derivable by the majority of participating cohorts and 
frequently needed as covariates or exposures in lifecourse 
research. The process adopted in LifeCycle to establish and 
harmonise these core variables for the EU Child Cohort Net-
work can be broken down into eight steps; an overview of 
these steps is displayed in Fig. 1. A glossary of the key ele-
ments and concepts described in this paper is also provided 
in Box 4.
Step 1: establishing a preliminary list of target core 
variables
LifeCycle partners with expertise in a wide range of fields 
including lifecourse epidemiology, public health, envi-
ronmental epidemiology, biology, statistics, paediatrics, 
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obstetrics, economics, demography, epigenomics and data 
science, met in a dedicated workshop (June 2017) to identify 
a preliminary list of core early-life stressors and exposures 
related to cardio-metabolic, respiratory and mental health 
outcomes using a consensus approach. This initial list was 
then further modified by drawing on experiences from other 
previous collaborative efforts such as MOBAND [50] and 
CHICOS (www. chico sproj ect. eu), and through consulting 
the literature and experts in the field, before being circulated 
amongst LifeCycle partners for further comment.
Steps 2, 3 & 4: collating codebooks, evaluating 
the harmonisation potential of each variable and finalising 
a list of target core variables
All cohorts participating in LifeCycle were requested to 
provide the coordinating team with cohort metadata (code-
books, questionnaires, instrument documentation, etc.). 
From these, the potential for each cohort to derive each 
target variable was established. The core variable list was 
then adapted in an iterative manner to achieve a balance 
between precision and inclusivity, ensuring a maximum 
number of cohorts could contribute data for numerous 
variables while maintaining data validity. Where possible, 
international standards and classification schemes were 
applied. For example, the International Standard Classifi-
cation of Occupation 1988 1-digit codes [51] were used to 
categorise parental occupation; the International Standard 
Classification of Education 97/2011 schemes [52, 53] were 
used to classify parental education; the WHO fetal growth 
charts [54] were used to establish size-for-gestational-age; 
the EUROCAT guide was used for classifying congenital 
anomalies. For some key exposures such as maternal smok-
ing, breastfeeding, childcare attendance and gestational 
age, several variables were included, with some variables 
capturing more information but at the cost of fewer cohorts 
being able to derive the variables. Repeated measures were 
also included, to capture the dynamic, longitudinal nature 
of many variables.
Step 5: pilot harmonisation
Data harmonisation was staggered across cohorts. First, 
an initial pilot harmonisation was conducted among four 
cohorts covering the majority of target core variables (the 
Danish National Birth Cohort, the EDEN mother-child 
cohort, the Generation R study and the Southampton Wom-
en’s Survey). This enabled any potential issues in the core 
Table 1  Pregnancy and child cohorts contributing data to the EU Child Cohort Network as of June 2020
a Number of children from the cohort contributing data to the EU Child Cohort Network and with all three of the following variables harmo-
nised: (1) birth weight, (2) sex, (3) at least one height or weight measurement taken at ≥ 1 year




ALSPAC (Avon Longitudinal Study of Parents & Children) UK 1991–1992 Pregnancy 25 10,742
BiB (Born in Bradford) UK 2007–2011 Pregnancy 9 12,397
CHOP (The EU Childhood Obesity Programme) Germany, Belgium, 
Italy, Spain and 
Poland
2002–2004 Birth 11 1280
DNBC (Danish National Birth Cohort) Denmark 1996–2002 Pregnancy 18 72,157
EDEN (Study on the pre- & early postnatal determinants of 
child health & development)
France 2003–2005 Pregnancy 8 1676
ELFE (Etude Longitudinale Francaise depuis l’Enfance) France 2011 Birth 7 10,825
GECKO (Groningen Expert Center for Kids with Obesity 
Drenthe Cohort)
The Netherlands 2006–2007 Pregnancy 10 2682
Gen R (Generation R) The Netherlands 2002–2006 Pregnancy 17 8534
HBCS (Helsinki Birth Cohort Study) Finland 1934–1944 Birth 76 13,343
INMA (INMA-Infancia y Medio Ambiente (Environment and 
Childhood Project))
Spain 1997–2008 Pregnancy 18 1900
MoBa (Norwegian Mother, Father and Child Cohort Study) Norway 1999–2008 Pregnancy 14 76,569
NFBC1966 (Northern Finland Birth Cohort 1966) Finland 1966 Pregnancy 46–48 7810
NFBC1986 (Northern Finland Birth Cohort 1986) Finland 1985–1986 Pregnancy 33–35 8372
NINFEA (Nascita e INFanzia: gli Effetti dell’Ambiente) Italy 2005–2016 Pregnancy 13 6018
Raine (The Raine Study) Australia 1989–1992 Pregnancy 26 2491
Rhea (Mother Child Cohort in Crete) Greece 2007–2008 Pregnancy 7 967
SWS (Southampton Women’s Survey) UK 1998–2007 Preconception 9 2921
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variable list to be identified and rectified. During the pilot 
harmonisation, the core variable list was revised iteratively 
through electronic communication, a workshop and a final 
teleconference.
Step 6: data harmonisation and local quality control
Harmonisation for the EU Child Cohort Network was car-
ried out locally by each participating cohort. This avoided 
any transfer of data but carried the risk of harmonisation 
protocols being interpreted differently by different cohorts. 
To limit this possibility, a detailed harmonisation manual 
was drawn up by the coordinating team, and supervision 
and feedback was maintained between the coordinating cen-
tre and each of the cohorts. The harmonisation manual is 
available to download from the LifeCycle website (https:// 
lifec ycle- proje ct. eu); it includes: (1) a final, annotated list of 
core variables, which, for each variable, includes: a variable 
name, a precise definition, a label, units, data type, permissi-
ble values and guidelines for what constitutes partial versus 
complete harmonisation (see Box 4 for definitions of partial 
vs. complete harmonisation); (2) relevant scale conversions; 
(3) relevant reference tables (e.g. WHO fetal growth charts, 
the EUROCAT guide for classifying congenital anomalies 
etc.). The harmonisation manual was circulated to cohorts in 
May 2018 and harmonisation of core variables by all cohorts 
was completed by May 2020. The duration of time that it 
took a cohort to harmonise all core variables ranged from 
three to eight months.
Once data were harmonised, each cohort was provided 
with detailed quality control instructions and scripts to 
check: (1) that variables matched the descriptions provided 
in the core variable list (name, datatype, values); (2) for out-
liers or improbable values; (3) for inconsistencies between 
non-repeated measures (e.g. all mothers coded as not smok-
ing during pregnancy were also coded as smoking zero ciga-
rettes during pregnancy); (4) for inconsistencies between 
repeated measures (e.g. children reducing height over time). 
Any inconsistencies identified were investigated on a cases-
by-case basis to establish which values were legitimate and 
which were errors, also in light of the other data available.
Step 7a: uploading harmonisation descriptions to the EU 
Child Cohort Network variable catalogue
To facilitate the utilisation of EU Child Cohort Network 
data for research, and ensure the complete and accurate 
documentation of harmonisation, an online catalogue of 
EU Child Cohort Network variables was developed using 
the Molgenis platform [55] (http:// catal ogue. lifec ycle- proje 
ct. eu). This open source, searchable catalogue includes 
detailed descriptions of each variable included in the EU 
Child Cohort Network (variable name, data type, values, unit 
and description), as well as details of which cohorts have 
harmonised each variable, whether that harmonisation was 
complete or partial, an explanation of how the variable was 
harmonised, plus the syntax and descriptions of the source 
variables used by each cohort to derive the variable (Fig. 2). 
For the core variables, documentation of harmonisation was 
conducted by each cohort and uploaded to the catalogue 
after harmonisation was complete.
The catalogue has been built using a logical tree struc-
ture, but variables can also be located using a search func-
tion (Fig. 3). There are plans to also incorporate descriptive 
summary statistics for each harmonised variable. Thus, the 
EU Child Cohort Network Variable Catalogue provides a 
comprehensive overview of the EU Child Cohort Network’s 
data, ensuring they are both findable and reusable, as well as 
contributing to the longer-term sustainability of the network.
Step 7b: uploading data to a data management platform 
for the federated analysis of data
To help ensure the sustainability and accessibility of the 
EU Child Cohort Network, an IT infrastructure has been 
implemented enabling the federated analysis of data. Full 
details of this infrastructure are given elsewhere [29, 56, 57]. 
Briefly, this infrastructure consists of secure Opal servers 
[58] located either at each host institution or on outsourced 
IT infrastructures. Once harmonisation is complete, each 
cohort uploads their harmonised data to their Opal server, 
where they remain stored, behind secure firewalls. Individ-
ual-level data are accessed via an RStudio Open Source cen-
tral analysis server (https:// rstud io. com/ produ cts/ rstud io/# 
rstud io- server) using the R-based platform DataSHIELD 
[56], which sends blocks of code to each Opal server and 
then combines the summary statistics that are sent back by 
each Opal server. There is no transfer of individual partici-
pant data to the researcher and a number of disclosure con-
trol filters ensure analyses are non-disclosive, thus the many 
ethical, legal and societal implications of transferring data 
from one site to another are avoided.
Step 8: central quality‑control
Quality of harmonised data was assessed at the central level 
by creating summary statistics for each core variable in R/
DataSHIELD. This was to identify outliers and improbable 
values and inconsistencies in data as outlined above, but also 
to identify large inconsistencies between cohorts. Where 
large inconsistencies were found, sampling and recruitment 
methods and differences in the instruments used to collect 
data were investigated, as well as the harmonisation process 
itself, in order to establish to what extent these differences 
were real versus an artefact of differing methodology.
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Results
Table 1 provides an overview of the 17 cohorts currently 
contributing data to the EU Child Cohort Network. As of 
June 2020, the network holds data on just under 250,000 
children and their parents, with contributing cohorts rang-
ing in size from 967 to 76,569 children. This is an initial 
number and will increase as new cohorts and their parent-
child triads join the network.
First and last year of recruitment of cohorts ranged 
between 1934 (HBCS) and 2016 (NINFEA) respec-
tively. Mean age of children at recruitment ranged from 
-1084 days before birth (approximately -3 years, in SWS, 
which recruited mothers before conception) to 17 days 
postpartum (in CHOP). The majority of mothers enrolled 
in the cohorts were recruited during pregnancy (13 of the 
17 currently participating cohorts).
Tables 2 and 3 summarise some key characteristics of 
the mother-child dyads from each cohort currently contrib-
uting data to the EU Child Cohort Network. Of note is the 
variation in the proportion of children born small and large 
for gestational age (ranging from 2.2% in CHOP to 11.2% 
in BiB and from 2.7% in CHOP to 14.2% in NFBC1986 for 
SGA and LGA respectively) and the proportion of children 
ever breastfed (ranging from 73.4% in EDEN to 99.6% 
in HBCS). Also of note is the variation in the proportion 
of mothers with a high level of education (ranging from 
3.3% in NFBC1966, most likely reflecting the earlier year 
of recruitment of this cohort, to 67.5% in MoBa) and the 
proportion of mothers who smoked during their pregnancy 
(ranging from 7.6% in NINFEA which is based in Italy, 
where the prevalence of smoking among women and espe-
cially pregnant women is known to be lower [59], to 33.1% 
in Rhea). Multiparity ranged between 27% in NINFEA and 
69% in NFBC1966.
Although we focus here on describing the EU Child 
Cohort Network’s core variables, the network also includes 
variables relating to the early-life exposome, encompass-
ing both the external environment (socio-economic, migra-
tion, urban environment and lifestyle factors) and internal 
environment (determined from biological markers such as 
DNA methylation, RNA expression and metabolomics), and 
outcome variables relating to cardio-metabolic, respiratory 
and mental health. An overview of all the themes of the EU 
Child Cohort Network is provided in Fig. 3, together with 
estimates of the total number of variables included in each 
theme. Due to the fact that new variables are continuously 
Table 2  Child-related characteristics of cohorts contributing data to the EU Child Cohort Network
Values are mean (standard deviation) or n (valid percent)
GA gestational age at birth, SGA small for gestational age, LGA large for gestational age, NA data not available
a Number of children from the cohort contributing data to the EU Child Cohort Network and with all three of the following variables harmo-
nised: i) birth weight, ii) sex, iii) at least one height or weight measurement taken at ≥ 1 year
b Birth weight ≤ 5th percentile for gestational age (in completed weeks) using the WHO fetal growth charts [52] as the growth standard
c Birth weight ≥ 95th percentile for gestational age (in completed weeks) using the WHO fetal growth charts [52] as the growth standard
Cohort Na Female, n (%) GA (weeks), 
mean (SD)
Birth weight (g), 
mean (SD)
SGAb, n (%) LGAc, n (%) Ever breastfed, n (%)
ALSPAC 10,742 5313 (49.5) 40.0 (1.9) 3408 (555) 644 (6.0) 1015 (9.5) 7213 (75.8)
BiB 12,397 5980 (48.2) 39.5 (1.8) 3212 (557) 1385 (11.2) 562 (4.5) 3228 (78.7)
CHOP 1280 659 (51.5) 40.4 (1.2) 3297 (351) 28 (2.2) 34 (2.7) 901 (70.4)
DNBC 72,157 35,464 (49.1) 39.9 (1.8) 3565 (582) 2281 (3.2) 10,046 (14.0) 55,214 (98.3)
EDEN 1676 802 (47.9) 39.7 (1.7) 3283 (506) 118 (7.0) 60 (3.6) 1230 (73.4)
ELFE 10,825 5277 (48.7) 39.6 (1.5) 3322 (488) 644 (6.0) 535 (5.0) 7858 (74.8)
GECKO 2682 1332 (49.7) 39.8 (1.6) 3542 (548) 87 (3.3) 357 (13.4) 1938 (79.4)
Gen R 8534 4229 (49.6) 40.3 (1.9) 3400 (576) 615 (7.4) 541 (6.5) 6013 (91.8)
HBCS 13,343 6369 (47.7) 39.8 (1.8) 3407 (479) NA NA 11,110 (99.6)
INMA 1900 923 (48.6) 39.9 (1.6) 3263 (467) 139 (7.3) 70 (3.7) 1648 (88.6)
MoBa 76,569 37,390 (48.8) 39.8 (1.9) 3576 (578) 2725 (3.6) 7377 (9.6) 71,768 (93.7)
NFBC1966 7810 3628 (46.5) 40.5 (1.9) 3491 (530) 378 (5.3) 703 (9.9) 4550 (86.0)
NFBC1986 8372 4112 (49.1) 39.8 (1.7) 3560 (546) 259 (3.1) 1186 (14.2) NA
NINFEA 6018 2951 (49.0) 39.7 (1.7) 3238 (493) 471 (7.9) 200 (3.3) 5502 (92.1)
Raine 2491 1218 (48.9) 39.1 (2.3) 3299 (602) 142 (7.0) 146 (7.2) 2082 (89.7)
Rhea 967 459 (47.5) 38.7 (1.5) 3183 (455) 56 (5.9) 51 (5.3) 805 (86.5)
SWS 2921 1411 (48.3) 39.7 (1.8) 3441 (547) 126 (4.3) 259 (8.9) 2376 (82.5)
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being added to the network with the inception of new 
research projects, these numbers are highly conservative.
The core variables consist of a set of 130 basic, princi-
pally lowest common denominator variables, available in 
the majority of participating cohorts and required for many 
analyses within the scope of LifeCycle and other lifecourse 
epidemiology research themes. Of these, seven are so-called 
“meta variables”, consisting of mother, child, pregnancy, 
and cohort identifiers, and variables providing the age of 
recruitment and country of cohort. The remaining variables 
consist of 96 non-repeated variables and 17 yearly-repeated 
variables with up to 18 measures between the ages of 0 
and < 18 years, together capturing maternal, paternal and 
child health, lifestyle, socio-demographic characteristics, 
mother’s obstetric history, birth outcomes and household 
exposures. There are also two trimester-repeated variables 
capturing maternal smoking and alcohol consumption dur-
ing pregnancy, four yearly-repeated variables with up to 
Fig. 1  The process adopted in LifeCycle to establish and harmonise the core variables for the EU Child Cohort Network
Box 1  A glossary of the key elements and concepts in LifeCycle
Term Definition
Complete harmonisation The ability to derive the variable as described in the harmonization manual, both in definition and format
Data harmonisation The process of creating a common dataset from disparate datasets
DataSHIELD An infrastructure and series of R packages that enables the remote and non-disclosive analysis of individual 
participant data
EU Child Cohort Network A network bringing together existing data from more than 250,000 European and Australian children and their 
parents
Federated data analysis Centralised analysis of individual participant data where data are stored on local servers and do not leave the 
host institution
Harmonisation manual A manual containing a list of target variables together with instructions for their harmonisation
Impossible harmonisation The complete inability to derive the variable due to no or limited information
Horizon2020 LifeCycle Project A collaboration between scientists from more than 17 existing pregnancy and child cohort studies
EU Child Cohort Network 
Variable Catalogue
An online catalogue providing an overview of available data in the EU Child Cohort Network, including details 
of how data have been created (http:// catal ogue. lifec ycle- proje ct. eu)
LifeCycle core variables A set of basic variables, derivable by the majority of cohorts participating in LifeCycle and frequently required 
in lifecourse analyses
Opal A data warehouse that is integrated with R and the DataSHIELD platform, allowing the analysis of data with-
out the physical sharing or disclosing of individual participant data
Partial harmonisation The ability to derive the variable as described but with some loss of information
572 A. Pinot de Moira et al.
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four measures between the ages of 0 and < 4 years captur-
ing childcare and four monthly-repeated variables with up 
to 216 height or weight measures between the ages of 0 and 
215 months. The full list of EU Child Cohort Network core 
variables is provided in Online Resource 1 and also in the 
EU Child Cohort Network Variable Catalogue (http:// catal 
ogue. lifec ycle- proje ct. eu). Since the EU Child Cohort Net-
work Variable Catalogue is dynamic and regularly expanded 
with both new variables and newly participating cohorts, the 
statistics reported there may differ from what is presented 
here.
Excluding the seven meta-variables, the percentage of 
core variables harmonised by cohorts ranged from 21% for 
HBCS to 92% for ELFE (Fig. 4). Missing variables are due 
to cohorts not having the data required to harmonise the 
variable. Twelve of the 17 cohorts currently included in the 
EU Child Cohort Network were able to harmonise at least 
50% of core variables completely, and 12 of the 17 cohorts 
were able to harmonise at least 75% of core variables either 
completely or partially.
Figures 5, 6 and 7 give an overview of the number of 
EU Child Cohort Network children (i.e. from all cohorts 
combined) with harmonised core data. Of the non-repeated 
core variables (Fig. 5), themes with the most complete data 
are those relating to maternal characteristics (specifically, 
age at birth, height, smoking during pregnancy, parity) and 
child-related characteristics (specifically, sex, gestational age 
at birth, birth weight, birth length, size for gestational age 
and death of the child), with more than 217,000 children as 
of June 2020 having harmonised data relating to these expo-
sures. Notably fewer children have data relating to mother 
and father’s country of birth and ethnic background, perhaps 
due to their sensitive nature [60].
An overview of the number of EU Child Cohort Net-
work children with harmonised yearly-repeated core vari-
ables, which allow for time-varying exposure statuses, is 
displayed in Fig. 6. Over 80% of children in the network 
have at least one harmonised measure of cohabitation 
status, mother’s occupational status, mother’s education 
level, father’s occupational status, father’s education level, 
Fig. 2  An illustration of the EU Child Cohort Network Variable Cata-
logue displaying the LifeCycle variable “maternal history of asthma 
before pregnancy”. Displayed is a description of the target EU Child 
Cohort Network variable and how the variable was harmonised in 
two separate cohorts. Note: descriptions from two separate cohorts 
are displayed on the same page for illustrative purposes only
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and child’s exposure to pets and cigarette smoke, whilst 
relatively few children (< 10%) have harmonised data on 
household income. For growth data (Fig. 7), the greatest 
density of measures in the network is between the ages 
of 0 and < 1 year, with a total of 780,993 and 732,202 
weight and height measurements available between these 
ages respectively, an average of three weight and height 
measures per child. Large amounts of growth data are also 
available for ages 1– < 2 years and 7– < 8 years, with over 
72% and 47% of children having harmonised weight and 
height data at these ages respectively, whilst relatively 
few children currently have weight and height data from 
14 years and onwards, partly because many cohorts have 
not yet reached that age.
Discussion
The Horizon 2020 LifeCycle Project is a collaboration 
between scientists from more than 17 pregnancy and birth 
cohorts from across Europe and Australia. It builds upon 
the expertise gained from previous collaborations such as 
the CHICOS, Enrieco and BioSHARE projects in order to 
establish an open and sustainable data resource known as 
the EU Child Cohort Network so as to facilitate research on 
the influence of early-life stressors on later health outcomes.
Here we have described the EU Child Cohort Network, 
focussing on its core variables, including the protocol devel-
oped to harmonise these data and thus make them interoper-
able. We have also described the EU Child Cohort Network 
Fig. 3  An illustration of the EU Child Cohort Network Variable Cata-
logue’s menu structure giving an overview of the themes included in 
the EU Child Cohort Network and the number of variables included 
in each theme. 1Including yearly-repeated variables with up to 18 
measures between the ages of 0 and < 18  years. 2Including weekly-
repeated variables with up to 43 measures taken between gestational 
weeks 0 and < 43. 3Including trimester-repeated variables with sepa-
rate measures for the first, second and third trimesters. 4Including 
separate variables indicating the type of father the variable relates 
to (biological, social father, social mother, unknown). 5Including 
separate variables relating to secondary father-figures.  6Including 
monthly-repeated variables with up to 216 measures between the 
ages of 0 and < 216 months. 7Including yearly-repeated variables with 
up to four measures between the ages of 0 and < 4 years. 8Including 
yearly-repeated variables with up to 13 measures between the ages of 
0 and < 13 years
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Variable Catalogue, developed to ensure that these and other 
data in the network are both findable and re-usable. These 
data will be analysed using a federated analysis platform, 
meaning there is no need to physically transfer data, and so 
data are ultimately more accessible to the researcher.
As well as the harmonised core data described here, 
the EU Child Cohort Network also contains data relat-
ing to the early-life exposome, and repeated measures of 
cardio-metabolic, respiratory and mental health. An addi-
tional feature of the network is the varied social, cultural and 
political environments of the cohorts. Thus, the EU Child 
Cohort Network constitutes an invaluable data resource, not 
only in terms of the number of participants included, but 
also in terms of its breadth, depth and diversity. This will 
ultimately enable the application of a range of analytical 
approaches to help infer causality, and identify possible tar-
get groups for improved cardio-metabolic, respiratory and 
mental health across the lifecourse.
However, the creation of such a data resource is not with-
out its limitations. Firstly, the resources required to create a 
common dataset, i.e. harmonise data, should not be underes-
timated. Harmonising data is difficult, time consuming and 
requires considerable investment by all involved. Although 
central harmonisation, whereby individual participant data 
are sent to one coordinating centre which harmonises all 
variables, is often viewed as the more optimal approach, this 
is not without its drawbacks. Firstly, there are many ethico-
legal challenges surrounding the transfer of data; secondly, 
it takes considerable investment by the data manager to 
become acquainted with a cohort’s data, scaled up 17 times 
in the case of the EU-Child Cohort Network, potentially 
leading to errors. It is for these reasons, and the fact that the 
EU Child Cohort Network is an open network, such that new 
cohorts are invited to join and are continually joining, that 
LifeCycle opted for local harmonisation. Here, harmonisa-
tion is carried out locally by each cohort, coordinated by a 
central coordinating centre. This of course has the limitation 
that harmonisation protocols may be interpreted differently 
Fig. 4  Percentage of EU Child Cohort Network core variables harmo-
nised by each cohort. The figure displays the percentage of the 123 
core variables listed in Online Resource 1 (excluding meta-variables) 
harmonised by each cohort. Shading of bars displays the degree of 
matching within each cohort: black bars represent percentage of com-
pletely harmonised variables; dark grey bars represent percentage of 
partially harmonised variables; light grey bars represent percentage of 
variables that were not harmonizable (impossible harmonisation)
Fig. 5  Harmonised non-repeated core variables in the EU Child 
Cohort Network. Bars display the number of children with either a 
partially (grey bars) or completely (black bars) harmonised core vari-
able for each of the main themes/exposures. The dashed line repre-
sents the total number of children (240,684), as of June 2020, con-
tributing data to the EU Child Cohort Network with all three of the 
following variables harmonised: (1) birth weight, (2) sex, (3) at least 
one height or weight measurement taken at ≥ 1 year. COB country of 
birth, PE pre-eclampsia, gest. HT gestational hypertension, size for 
GA size for gestational age
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Fig. 6  Number of children in 
the EU Child Cohort Network 
with yearly-repeated measure 
core variables. Bars display the 
number of children with at least 
one measure between the ages 
of zero and three (child-care 
variables) or zero and seventeen 
(all other variables), either par-
tially (grey bars) or completely 
(black bars) harmonised. The 
dashed line represents the total 
number of children (240,684), 
as of June 2020, contributing 
data to the EU Child Cohort 
Network with all three of the 
following variables harmonised: 
i) birth weight, ii) sex, iii) at 
least one height or weight meas-
urement taken at ≥ 1 year
Fig. 7  Weight and height data 
in the EU Child Cohort Net-
work. Graphs display a number 
of children in the network 
with at least one weight (dark 
grey bars) or height (light grey 
bars) measure at < 3 months, 
3–6 months, 6–12 months 
and yearly intervals from 1 to 
17 years; b total number of 
weight (dark grey bars) and 
height (light grey bars) within 
each age band (i.e. one child 
may contribute multiple meas-
urements within each age band)
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by different cohorts. We have tried to limit this possibility 
in LifeCycle by providing detailed instructions and main-
taining regular contact with data managers. We have also 
implemented a number of data quality checks, applied both 
locally and centrally. These include checks to ensure that 
harmonised variables match those detailed in the harmonisa-
tion manual and to identify outliers or improbable values, or 
any inconsistencies in measures within or between cohorts. 
Good documentation of all harmonisation steps is key to 
diagnosing any inconsistencies, which we have ensured in 
LifeCycle by establishing the EU Child Cohort Network 
Variable Catalogue.
Another drawback of data harmonisation is that the end 
product is often the “lowest common denominator”. For 
any given variable, some cohorts will inevitably have more 
detailed variables than other cohorts. In an attempt to create 
a common variable achievable by all cohorts, more detailed 
variables are stripped down to simpler versions, inevitably 
resulting in some loss of information. This may also involve 
deciding that in some cohorts there is insufficient data to 
harmonise a variable. Harmonisation is thus a balancing act 
between retaining as much information as possible while 
ensuring data are fully comparable [61].
So, if the creation of a common dataset is such a tremen-
dous task and the end product may, in some instances, be 
less detailed than the original data, why bother? Increased 
statistical power is one obvious advantage. Combining data 
from several cohorts to increase power allows rarer, but 
equally important and often more devastating [62], diseases 
and rare determinants to be studied. Larger sample sizes also 
allow for more powerful statistical analyses, such as explor-
ing multiple interactions, complex nonlinear relationships, 
small effects or dose responses [63]. While national registers 
offer the possibility of creating birth cohorts of an order of 
magnitude larger than the EU Child Cohort (for e.g. Nordic 
register-based cohort studies [64, 65]), these typically lack 
the in-depth lifestyle and behavioural data obtained from 
questionnaires, or physiological data obtained from detailed 
clinical examinations. National register data are in addition 
likely to offer less diversity with respect to social, cultural 
and political environment. Cross-cohort collaborations also 
allow fine resolution biological data to be shared, such as 
medical images or metagenomic data, that may be prohibi-
tively costly to obtain from the entire cohort and therefore 
only collected from a sub-population of the cohort.
A larger sample size is not the only benefit of cross-
cohort collaborations. Combining data also offers the 
opportunity to study populations typically under-repre-
sented in cohort studies, for example individuals from 
lower socio-economic backgrounds or ethnic minority 
groups. Heterogeneities between cohorts can be utilised 
to strengthen causal inference. For example, differing 
confounding structures allows the untangling of true 
associations, whilst replication of findings across differ-
ent populations with differing gene pools, and cultural and 
socio-economic structures, helps to rule out chance find-
ings while also establishing the generalisability of results. 
Geographical, intergenerational and period effects can also 
be examined to find new associations and generate new 
hypotheses.
While it could be argued that an easier and potentially 
less time-consuming approach to combining data from sev-
eral studies is the more conventional systematic review and 
meta-analysis of published data, this has a number of dis-
advantages compared to individual participant data (IPD) 
meta-analysis. Published data are often subject to selective 
reporting and publication bias, lack harmonised measures, 
and offer limited scope and flexibility in terms of statistical 
analysis, and few opportunities, if any, for data checking 
[66, 67].
The added value that the collaboration itself brings 
should also be highlighted: the opportunity to share ideas 
and methodology, learn from each other, and ultimately 
strengthen research outputs. Also the increased use of data 
and exchange opportunities for researchers. Scientific col-
laboration also facilitates the dissemination of both results 
and ideas/hypotheses, as well as creating opportunities for 
interdisciplinary research.
In conclusion, the EU Child Cohort Network offers an 
invaluable data resource for studying how early-life expo-
sures influence health trajectories throughout the lifecourse. 
This is both in terms of the number of its participants, and 
the breadth and depth of its data. Here we share the approach 
taken within LifeCycle to harmonise the network’s core 
data and describe the EU Child Cohort Network Variable 
Catalogue established to ensure that the network’s data are 
both findable and reusable. We also highlight some of the 
great benefits of cross-cohort collaboration. Having hope-
fully convinced the reader of the benefits of the EU Child 
Cohort Network and similar cross-cohort collaborations, we 
end with a plea to other cohorts to join the network and 
share their data, and to researchers to utilise this incredible 
resource. Both cohorts and researchers can join the network 
by contacting lifecycle@erasmusmc.nl.
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